Chinese 
English 
Russian 
French 博客
Stem Cell Therapy for Osteoporosis: What 2026 Research Means for Women After Menopause
Osteoporosis after menopause affects millions of women. New 2026 research shows mesenchymal stem cells and exosomes can rebuild bone density safely. Here’s what patients need to know.
Aug 16, 2026
Exosome Therapy for ALS: A New Wave of Hope Arrives in Bangkok
If you or someone you love is living with ALS (Amyotrophic Lateral Sclerosis), you already know the hardest part of the diagnosis: being told to wait. Wait for research. Wait for trials. Wait for something to change. But…
Aug 15, 2026
Stem Cell Therapy for Dry Age-Related Macular Degeneration: Your 2026 Guide to Vision Restoration
Explore the latest 2026 research on stem cell therapy for dry Age-Related Macular Degeneration (AMD). Learn how RPE cell transplantation and clinical trials offer new hope for restoring vision. Consult Cell La Vie.
Aug 14, 2026
MSC Therapy for Burn Wounds and Chronic Skin Regeneration: 2026 Breakthroughs in Exosome-Based Healing
New 2026 research reveals UC-MSC exosomes combined with low-intensity pulsed ultrasound and curcumin-hydrogel systems achieve remarkable burn wound healing — including MRSA-infected wounds — through autophagy regulation,…
Aug 14, 2026
Stem Cells and Alzheimer’s Disease: A Patient’s Guide to What 2026 Research Shows
2026 patient guide to MSC therapy for Alzheimer’s disease: how it differs from lecanemab and donanemab, who is a candidate, what outcomes to expect, the 6 active clinical trials including NCT06775964 and the first MSC + …
Aug 13, 2026
Is Stem Cell Therapy Legal and Safe in Thailand? (2026 Patient Guide)
Is Stem Cell Therapy Legal and Safe in Thailand? For international patients considering regenerative treatments, traveling abroad for stem cell therapy brings both immense hope and important practical questions. As medic…
Aug 13, 2026
The First FDA-Approved Stem Cell Therapy for Type 1 Diabetes: What Zimislecel Means for Patients in 2026
Zimislecel (VX-880) is the first stem cell-derived islet therapy to reach the FDA, and the September 2025 NEJM paper showed 12 of 12 patients achieving insulin independence. Here’s what it means for T1D patients in 2026,…
Aug 13, 2026
MSC Exosome and Stem Cell Therapy for Psoriasis: 2026 Mechanism, Trials, and Clinical Landscape
5 MSC and exosome trials for psoriasis have reported completion; three 2026 mechanistic studies reveal novel Ang1/Tie2 angiogenesis mechanisms, engineered exosome-nanoparticle platforms, and culture medium optimization f…
Aug 13, 2026
MSC Therapy for Degenerative Disc Disease: A 2026 Meta-Analysis of Randomized Trials and the Cell-Free Exosome Frontier
A 2026 meta-analysis of 7 randomized trials confirms intradiscal MSC injections reduce chronic back pain and disability significantly. Meanwhile, bioengineered exosome therapies are redefining what cell-free disc regener…
Aug 12, 2026
MSC Therapy for Peripheral Arterial Disease and Critical Limb Ischemia: 2026 Clinical and Mechanistic Breakthroughs
CRISPR-edited MSCs, iPSC-derived cells, combinatorial cell therapy, and exosome-based approaches are transforming PAD/CLI treatment. Six landmark 2026 papers and five active clinical trials reviewed for clinicians and re…
Aug 12, 2026
MSC Therapy for Pulmonary Arterial Hypertension: Mechanisms, Mitochondrial Repair.
Pulmonary arterial hypertension kills half its patients within five years. 2026 research shows mesenchymal stem cells — especially HO-1-modified and mitochondria-primed MSCs — are reversing the vascular remodeling at the…
Aug 12, 2026
Can Stem Cell Exosomes Restore Hearing? What the 2026 Breakthrough Means for You
A 2026 Phase 1 trial showed that MSC-derived exosomes injected into the ear were safe and improved hearing in patients with sudden sensorineural hearing loss. Here’s what the breakthrough means and when it could be avail…
Aug 12, 2026
Page 2 of 13 — 147 posts